EUCTR2008-005306-39-DE进行中（未招募）1 期
Food supplementation with Vitamin K for MGP-activation and inhibition of progression of aortic valve calcification
RWTH Aachen University, represented by the rector, himself represented by Clinical Trial Center Aachen (CTC-A)0 个研究点目标入组 140 人开始时间: 2008年11月19日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •patients with echocardiographic determined aortic valve calcification >= 50 years of age
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 140
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 140
排除标准
- •chronic or acute intestinal diseases
- •terminal renal failure
- •known soy allergy
- •actual Vitamin K supplementation
- •oral intake of vitamin K antagonists (e.g. Marcumar)
- •systemic cortisone therapy
- •present medical history of thrombosis
研究者
相似试验
已完成
不适用
Investigating the effect of vitamin K supplementation on markers of bone turnover and bone density in adolescents and adults with cystic fibrosisCystic fibrosisISRCTN14200211Barts and the London NHS Trust (UK)40
已完成
2 期
the effect of vitamin K supplementation on bone factors in hemodialysis patientsIRCT20221217056845N1Gorgan University of Medical Sciences72
进行中（未招募）
1 期
To investigate the effect of vitamin K supplementation on markers of bone turnover and bone density in adolescents and adults with cystic fibrosis - Vitamin K supplementation in Cystic FibrosisCystic FibrosisEUCTR2006-000945-20-GBBarts and the London NHS Trust40
进行中（未招募）
1 期
Vitamin K in OsteoporosisEUCTR2010-022587-12-GBGuy's and St. Thomas' NHS Foundation Trust105
招募中
3 期
Effect of vitamin K2 ( MK-7 ) in treatment of diabetesIRCT20190824044592N1Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences68